Literature DB >> 19361447

First inactive conformation of CK2 alpha, the catalytic subunit of protein kinase CK2.

Jennifer Raaf1, Olaf-Georg Issinger, Karsten Niefind.   

Abstract

The Ser/Thr kinase casein kinase 2 (CK2) is a heterotetrameric enzyme composed of two catalytic chains (CK2alpha, catalytic subunit of CK2) attached to a dimer of two noncatalytic subunits (CK2beta, noncatalytic subunit of CK2). CK2alpha belongs to the superfamily of eukaryotic protein kinases (EPKs). To function as regulatory key components, EPKs normally exist in inactive ground states and are activated only upon specific signals. Typically, this activation is accompanied by large conformational changes in helix alpha C and in the activation segment, leading to a characteristic arrangement of catalytic key elements. For CK2alpha, however, no strict physiological control of activity is known. Accordingly, CK2alpha was found so far exclusively in the characteristic conformation of active EPKs, which is, in this case, additionally stabilized by a unique intramolecular contact between the N-terminal segment on one side, and helix alpha C and the activation segment on the other side. We report here the structure of a C-terminally truncated variant of human CK2alpha in which the enzyme adopts a decidedly inactive conformation for the first time. In this CK2alpha structure, those regulatory key regions still are in their active positions. Yet the glycine-rich ATP-binding loop, which is normally part of the canonical anti-parallel beta-sheet, has collapsed into the ATP-binding site so that ATP is excluded from binding; specifically, the side chain of Arg47 occupies the ribose region of the ATP site and Tyr50, the space required by the triphospho moiety. We discuss some factors that may support or disfavor this inactive conformation, among them coordination of small molecules at a remote cavity at the CK2alpha/CK2beta interaction region and binding of a CK2beta dimer. The latter stabilizes the glycine-rich loop in the extended active conformation known from the majority of CK2alpha structures. Thus, the novel inactive conformation for the first time provides a structural basis for the stimulatory impact of CK2beta on CK2alpha.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19361447     DOI: 10.1016/j.jmb.2009.01.033

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  17 in total

1.  Structure of the Toxoplasma gondii ROP18 kinase domain reveals a second ligand binding pocket required for acute virulence.

Authors:  Daniel Lim; Daniel A Gold; Lindsay Julien; Emily E Rosowski; Wendy Niedelman; Michael B Yaffe; Jeroen P J Saeij
Journal:  J Biol Chem       Date:  2013-10-15       Impact factor: 5.157

2.  Enzymatic activity with an incomplete catalytic spine: insights from a comparative structural analysis of human CK2α and its paralogous isoform CK2α'.

Authors:  Nils Bischoff; Jennifer Raaf; Birgitte Olsen; Maria Bretner; Olaf-Georg Issinger; Karsten Niefind
Journal:  Mol Cell Biochem       Date:  2011-07-08       Impact factor: 3.396

3.  Conformational flexibility of human casein kinase catalytic subunit explored by metadynamics.

Authors:  Aurélie Gouron; Anne Milet; Helene Jamet
Journal:  Biophys J       Date:  2014-03-04       Impact factor: 4.033

4.  Protein kinase-inhibitor database: structural variability of and inhibitor interactions with the protein kinase P-loop.

Authors:  Ronak Y Patel; Robert J Doerksen
Journal:  J Proteome Res       Date:  2010-09-03       Impact factor: 4.466

5.  Structural and functional insights into the regulation mechanism of CK2 by IP6 and the intrinsically disordered protein Nopp140.

Authors:  Won-Kyu Lee; Sang Hyeon Son; Bong-Suk Jin; Jung-Hyun Na; Soo-Youl Kim; Kook-Han Kim; Eunice Eunkyeong Kim; Yeon Gyu Yu; Hyung Ho Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

6.  Dynamic regulation of a metabolic multi-enzyme complex by protein kinase CK2.

Authors:  Songon An; Minjoung Kyoung; Jasmina J Allen; Kevan M Shokat; Stephen J Benkovic
Journal:  J Biol Chem       Date:  2010-02-15       Impact factor: 5.157

7.  Cystic fibrosis transmembrane regulator fragments with the Phe508 deletion exert a dual allosteric control over the master kinase CK2.

Authors:  Mario A Pagano; Oriano Marin; Giorgio Cozza; Stefania Sarno; Flavio Meggio; Kate J Treharne; Anil Mehta; Lorenzo A Pinna
Journal:  Biochem J       Date:  2010-01-27       Impact factor: 3.857

8.  Structural basis for decreased affinity of Emodin binding to Val66-mutated human CK2 alpha as determined by molecular dynamics.

Authors:  Na Zhang; Rugang Zhong
Journal:  J Mol Model       Date:  2009-10-11       Impact factor: 1.810

9.  2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 1. Identification of an Allosteric Binding Site.

Authors:  Benoît Bestgen; Isabelle Krimm; Irina Kufareva; Ahmed Ashraf Moustafa Kamal; Wei-Guang Seetoh; Chris Abell; Rolf W Hartmann; Ruben Abagyan; Claude Cochet; Marc Le Borgne; Matthias Engel; Thierry Lomberget
Journal:  J Med Chem       Date:  2019-02-18       Impact factor: 7.446

10.  2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 2. Structure-Based Optimization and Investigation of Effects Specific to the Allosteric Mode of Action.

Authors:  Benoît Bestgen; Irina Kufareva; Weiguang Seetoh; Chris Abell; Rolf W Hartmann; Ruben Abagyan; Marc Le Borgne; Odile Filhol; Claude Cochet; Thierry Lomberget; Matthias Engel
Journal:  J Med Chem       Date:  2019-02-13       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.